Advanced Therapies Manufacturing

 

Advanced Therapies Manufacturing, Monday 11 July 2022

last published: 20/May/22 23:45
 

Advanced Therapies Manufacturing, Tuesday 12 July 2022

08:30

Organizer Opening Remarks

08:35

Chair Opening Remarks

Emil Kakkis
08:40

Keynote Address: Drug Development in the 21st Century - The use of primary disease activity biomarkers to establish efficacy

Keynote speaker to be announced
09:35

Keynote Address: Reserved for FDA Commissioner

Advanced Therapies Manufacturing
11:15

In-house vs external contracting for ramping up gene therapy manufacturing

Speaker to be announced
Advanced Therapies Manufacturing
11:35

Session title to be announced

Sponsored by Cardinal Health
Phillip Brooks
Advanced Therapies Manufacturing
11:55

Bespoke Gene Therapy Consortium - update on how to move therapies through the clinic more rapidly

Abhi Gupta
Advanced Therapies Manufacturing
12:15

Manufacturing for advanced gene therapies

Matthew Hewitt
Advanced Therapies Manufacturing
15:35

Utilizing an end-to-end portfolio approach to de-risk rare and/or orphan disease program development

Advanced Therapies Manufacturing
15:55

Creating effective redundancy plans for gene and cell therapy manufacturing in global commercialization rollout

Speaker to be announced
Antonino Severino
Advanced Therapies Manufacturing
16:15

From development, through clinical trials to Commercial production – CMO perspective

last published: 20/May/22 23:45

 

 

Get Involved At World Orphan Drug Congress USA

 

To Sponsor Or Exhibit

 
 

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

 

 

 

To Speak

 
 

Claire Murphy
claire.murphy@terrapinn.com
t/ +1 646 619 1784

 

 

 

Marketing & Press Opportunities

 
 

Taylor Post 
taylor.post@terrapinn.com
t/ +1 646 619 1785